iHuman Inc. Sponsored ADR (NYSE:IH) Short Interest Update
by Jessica Moore · The Cerbat GemiHuman Inc. Sponsored ADR (NYSE:IH – Get Free Report) was the recipient of a significant decline in short interest in April. As of April 30th, there was short interest totaling 4,205 shares, a decline of 46.6% from the April 15th total of 7,876 shares. Based on an average daily volume of 7,975 shares, the short-interest ratio is currently 0.5 days. Approximately 0.0% of the company’s stock are short sold.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of iHuman in a research report on Friday, April 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.
Read Our Latest Stock Report on iHuman
iHuman Price Performance
IH traded up $0.02 during trading on Monday, reaching $1.67. 6,486 shares of the stock traded hands, compared to its average volume of 11,951. The stock has a market cap of $85.10 million, a price-to-earnings ratio of 6.66 and a beta of 0.16. iHuman has a fifty-two week low of $1.55 and a fifty-two week high of $3.60. The stock’s 50-day simple moving average is $1.75 and its two-hundred day simple moving average is $2.06.
iHuman (NYSE:IH – Get Free Report) last released its quarterly earnings data on Tuesday, March 31st. The company reported $0.04 earnings per share (EPS) for the quarter. The firm had revenue of $27.25 million during the quarter. iHuman had a return on equity of 9.79% and a net margin of 11.80%.
iHuman Dividend Announcement
The business also recently announced an annual dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 17th were issued a dividend of $0.10 per share. This represents a yield of 573.0%. The ex-dividend date was Friday, April 17th.
Hedge Funds Weigh In On iHuman
A hedge fund recently bought a new stake in iHuman stock. Acadian Asset Management LLC bought a new stake in shares of iHuman Inc. Sponsored ADR (NYSE:IH – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 15,067 shares of the company’s stock, valued at approximately $32,000. Institutional investors and hedge funds own 4.92% of the company’s stock.
About iHuman
iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.